小分子在丙肝中的治疗——机会与挑战
——  作者:    时间:2008-08-05     阅读数: 1325

简介:Debio 025 at daily doses of 1000 or 600 mg demonstrates an additive anti-HCV effect in combination with PegIFNa-2a. This effect was more evident in patients with genotype 1 & 4.Debio 025 in daily doses of 200 or 600 mg in combination with PegIFNa-2a was well tolerated and the majority of reported adverse events were known side effects of alpha interferons.

请登录后查看详细内容

发表评论

全部评论